NEW DELHI: The government on Tuesday cancelled the licenses of 18 pharma companies for manufacturing of spurious medicines following an inspection by the Drugs Controller General of India (DCGI) on 76 companies across 20 states.
“Huge crackdown under way on pharma companies across the country related to manufacturing of spurious medicines,” news agency ANI reported quoting sources.
“Action on 70 companies in Himachal Pradesh and 45 in Uttarakhand and 23 in Madhya Pradesh during government crackdown on companies manufacturing spurious medicines,” it added.